US0718131099
© BusinessWire
13.12.2025
BAX
LISTED
NYSE
Deadline Soon: Baxter International, Inc. (BAX) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming December 15, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Baxter International, Inc. ("Baxter" or the "Company") (NYSE: BAX) securities between February 23, 2022 and October 29, 2025, inclusi...
Themefolio
Profiler
Peergroup
© BusinessWire
11.12.2025
BAX
LISTED
NYSE
Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity
News Preview
Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The University of Texas Medical Branch (UTMB Health) demonstrating the positive impact of smart infusion pump integration with hospital electronic medical records (EMRs) on patient safety, clinicians' bedsid...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
BAX
LISTED
NYSE
Baxter Announces Pricing of Tender Offers for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027
News Preview
Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the consideration payable in connection with the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The table below sets forth the Total Consideration (as defined below) for each series of Notes.
Title of
Security...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
04.12.2025
BAX
LISTED
NYSE
Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027
News Preview
Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the early tender results for the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The tender offers are being made pursuant to the terms and conditions set forth in the offer to purchase, dated Nov. 19, 2025, as amende...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
19.11.2025
BAX
LISTED
NYSE
Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027
News Preview
Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced that it has increased the maximum purchase price for its $1.45 billion aggregate principal amount outstanding of 1.915% Senior Unsecured Notes due 2027 (the “2027 Notes”) that it can repurchase under its previously announced cash tender offer for the 2027 Notes (the “...
Themefolio
Profiler
Peergroup
© BusinessWire
11.11.2025
BAX
LISTED
NYSE
Baxter Declares Quarterly Dividend
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.01 per share of common stock. The dividend is payable on Jan. 2, 2026, to stockholders of record as of Nov. 28, 2025. The indicated annual dividend rate equates to $0.04 per share of common stock....
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
BAX
LISTED
NYSE
The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University
News Preview
The Baxter Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the continuation of a partnership with Northwestern University’s School of Education and Social Policy (SESP) to provide science, technology, engineering and math (STEM) programs for students and teachers throughout the Ch...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
BAX
LISTED
NYSE
Baxter International, Inc. DEADLINE ALERT: Baxter International, Inc. Investors Urged to Contact Kirby McInerney LLP About Class Action Lawsuit
News Preview
Kirby McInerney LLP reminds Baxter International, Inc. (“Baxter” or the “Company”) (NYSE:BAX) investors of the December 15, 2025 deadline to seek the role of lead plaintiff in a pending federal securities class action.
If you purchased or otherwise acquired Baxter International, Inc. securities, have information, or would like to learn more, plea...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
BAX
LISTED
NYSE
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Baxter International
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
BAX
LISTED
NYSE
Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
BAX
LISTED
NYSE
Baxter Reports Third-Quarter 2025 Results
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2025.
“I joined Baxter because it’s a global healthcare leader – an iconic brand with an essential portfolio that touches more than 350 million patients every year,” said Andrew Hider, president and CEO. “In my first weeks, I’ve seen fi...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
BAX
LISTED
NYSE
Deadline Approaching: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).
IF YOU ARE...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
28.10.2025
BAX
LISTED
NYSE
Law Offices of Frank R. Cruz Encourages Baxter International, Inc. (BAX) Shareholders to Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”). Baxter investors have until December 15, 2025 to file a lead plain...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
BAX
LISTED
NYSE
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Baxter International, Inc. (BAX) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
BAX
LISTED
NYSE
BAX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”), have until December 15, 2025 to seek appointment as lead plaintiff of the Baxter class action lawsuit. Captioned Electrical W...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
BAX
LISTED
NYSE
Law Offices of Howard G. Smith Encourages Baxter International, Inc. (BAX) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”). Baxter investors have until December 15, 2025 to file a lead plaintiff...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
BAX
LISTED
NYSE
Securities Fraud Investigation Into Baxter International, Inc. (BAX) Announced – Shareholders Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON BAX...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
BAX
LISTED
NYSE
Baxter International, Inc. (BAX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BAXTER INTERNATIONAL, INC. (BAX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABO...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
BAX
LISTED
NYSE
BAX INVESTORS: Kirby McInerney LLP Reminds Baxter International, Inc. Investors of Important Deadline in Class Action Lawsuit
News Preview
If you have suffered a loss on your Baxter International, Inc. (“Baxter” or the “Company”) (NYSE:BAX) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
Investors have until...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
BAX
LISTED
NYSE
Securities Fraud Investigation Into Baxter International, Inc. (BAX) Announced – Shareholders Who Lost Money Urged to Contact the Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON BAXTER INTERNATIONAL, INC. (BAX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUI...
Themefolio
Profiler
Peergroup
© BusinessWire
21.10.2025
BAX
LISTED
NYSE
BAX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, both dates inclusive (the “Class Period”), have until December 15, 2025 to seek appointment as lead plaintiff of the Baxter class action lawsuit. Captioned E...
Themefolio
Profiler
Peergroup
© BusinessWire
20.10.2025
BAX
LISTED
NYSE
Baxter International Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BAX
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of BAX during th...
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2025
BAX
LISTED
NYSE
Rosen Law Firm Urges Baxter International Inc. (NYSE: BAX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of Baxter International Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, both dates inclusive (the “Class Period”). Baxter develops, manufactures, and markets medical products....
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2025
BAX
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX) and reminds investors of the December 15, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faru...
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2025
BAX
LISTED
NYSE
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission....
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2025
BAX
LISTED
NYSE
Labaton Keller Sucharow LLP Files Securities Class Action Against Baxter International, Inc. and Certain of Its Executives
News Preview
Labaton Keller Sucharow LLP (“Labaton”) has filed a securities class action lawsuit (the “Action”) on behalf of its client the Electrical Workers Pension Fund, Local 103, I.B.E.W. (“Local 103”) against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) and certain of its executives (collectively, “Defendants”). The Action, which is...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
BAX
LISTED
NYSE
Baxter to Host Third-Quarter 2025 Financial Results Conference Call for Investors
News Preview
Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its third-quarter 2025 financial results on Thursday, October 30, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I156235 to pre-register for the call an...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
BAX
LISTED
NYSE
Baxter is First Manufacturer to Achieve Gold Resiliency Badge for IV Solutions, Nutrition Solutions and Premix Drugs from Healthcare Industry Resilience Collaborative (HIRC)
News Preview
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has been awarded a Gold Level Resiliency Badge from the Healthcare Industry Resilience Collaborative (HIRC) in the categories of IV Solutions, Nutrition Solutions and Premix Drugs. Baxter is the first manufacturer to earn this distinction across these c...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
BAX
LISTED
NYSE
Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring
News Preview
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today launched the Welch Allyn Connex 360 Vital Signs Monitor, its next generation patient monitoring device. As the latest innovation in Baxter’s connected monitoring portfolio, Connex 360 offers an advanced connectivity and security platform, customizable configurations base...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
BAX
LISTED
NYSE
Surgeons Convene at Vienna Symposium to Experience Baxter's HEMOPATCH Sealing Hemostat
News Preview
DEERFIELD, Ill., Aug. 18, 2025 /PRNewswire/ --
Trusted for Over a Decade.For over a decade, Hemopatch sealing hemostat has been a trusted companion in surgeries worldwide, providing critical support and precision under pressure, while evolving with the healthcare landscape.
A New Milestone: HEMOPATCH Sealing Hemostat, Now in Room TemperatureAt a...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
BAX
LISTED
NYSE
Chirurgen treffen sich auf dem Wiener Symposium, um Baxters HEMOPATCH Sealing Hemostat kennenzulernen
News Preview
DEERFIELD, Illinois, 18. August 2025 /PRNewswire/ --
Seit über einem Jahrzehnt vertrauenswürdig. Seit über einem Jahrzehnt ist der Hemopatch Sealing Hemostat ein zuverlässiger Begleiter bei Operationen weltweit. Er bietet wichtige Unterstützung und Präzision unter Druck und entwickelt sich gleichzeitig mit dem Gesundheitswesen weiter.
Ein neuer...
Themefolio
Profiler
Peergroup
© BusinessWire
31.07.2025
BAX
LISTED
NYSE
Baxter Reports Second-Quarter 2025 Results
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2025.
“For the second quarter of 2025, Baxter delivered performance in line with guidance while our employees across the globe continued advancing the company’s life-sustaining Mission and building on its vision to redefine healthcare...
Themefolio
Profiler
Peergroup
© BusinessWire
17.07.2025
BAX
LISTED
NYSE
Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2025 financial results on Thursday, July 31, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I156238 to pre-register for the call and receive t...
Themefolio
Profiler
Peergroup
© BusinessWire
14.07.2025
BAX
LISTED
NYSE
Baxter Declares Quarterly Dividend
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on October 1, 2025, to stockholders of record as of August 29, 2025. The indicated annual dividend rate is $0.68 per share of common stock.
A...
Themefolio
Profiler
Peergroup
© BusinessWire
07.07.2025
BAX
LISTED
NYSE
Baxter Appoints Andrew Hider Chief Executive Officer
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a member of its board of directors. Mr. Hider will assume his responsibilities at Baxter no later than Sept. 3, 2025, or an earlier date pending completion of his current employment comm...
Themefolio
Profiler
Peergroup
© BusinessWire
24.06.2025
BAX
LISTED
NYSE
Baxter Publishes Annual Corporate Responsibility Report, Demonstrating Ongoing Action to Make a Meaningful Difference Around the World
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2024 Corporate Responsibility Report. The annual report demonstrates Baxter's commitment to transparent reporting and provides updates on the company’s 2030 Corporate Responsibility Commitment and Goals,1 which strive to create a more sustainable and responsible bus...
Themefolio
Profiler
Peergroup
© BusinessWire
27.05.2025
BAX
LISTED
NYSE
BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Tuesday, June 10, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 10:40 a.m. Eastern Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and...
Themefolio
Profiler
Peergroup
© PR Newswire
20.05.2025
BAX
LISTED
NYSE
Baxter bringt HEMOPATCH Sealing Hemostat auf den Markt, ein bei Raumtemperatur verwendbares Kollagenpflaster, das für die Blutstillung und Versiegelung zugelassen ist und sich für offene Operationen und minimalinvasive chirurgische Eingriffe (MIS) eignet
News Preview
DEERFIELD, Illinois, 20. Mai 2025 /PRNewswire/ -- „Hemopatch Sealing Hemostat ist eine bedeutende Entwicklung von Baxter, und die Einführung der Variante für Raumtemperatur unterstreicht unser kontinuierliches Engagement für Innovationen im Bereich des Gewebemanagements", erklärte Steve Wallace, President of Advanced Surgery bei Baxter.
Aufbauen...
Themefolio
Profiler
Peergroup
© PR Newswire
20.05.2025
BAX
LISTED
NYSE
Baxter launches HEMOPATCH Sealing Hemostat, a room-temperature collagen pad approved for Hemostasis and Sealing, suitable for open surgery and minimally invasive surgical procedures (MIS)
News Preview
DEERFIELD, Ill., May 20, 2025 /PRNewswire/ -- "Hemopatch Sealing Hemostat represents a significant development from Baxter, and introducing the room-temperature variant highlights our ongoing dedication to innovation in Tissue Management," stated Steve Wallace, President of Advanced Surgery at Baxter.
Building on a decade of market success, Baxt...
Themefolio
Profiler
Peergroup
© BusinessWire
06.05.2025
BAX
LISTED
NYSE
Baxter Declares Quarterly Dividend
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on July 1, 2025, to stockholders of record as of May 30, 2025. The indicated annual dividend rate is $0.68 per share of common stock.
About Ba...
Themefolio
Profiler
Peergroup
© BusinessWire
01.05.2025
BAX
LISTED
NYSE
Baxter Reports First-Quarter 2025 Results
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2025.
“Our solid performance in the first quarter of 2025 reflects the ongoing impact of our transformation journey,” said Brent Shafer, chair and interim chief executive officer. “Baxter today is a more focused and agile organization, w...
Themefolio
Profiler
Peergroup
© BusinessWire
29.04.2025
BAX
LISTED
NYSE
Baxter to Present at Bank of America Securities 2025 Health Care Conference
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Pacific Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be...
Themefolio
Profiler
Peergroup
© BusinessWire
15.04.2025
BAX
LISTED
NYSE
Baxter to Host First-Quarter 2025 Financial Results Conference Call for Investors
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2025 financial results on Thursday, May 1, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I763359 to pre-register for the call and receive the...
Themefolio
Profiler
Peergroup
© BusinessWire
10.04.2025
BAX
LISTED
NYSE
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
News Preview
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding...
Themefolio
Profiler
Peergroup
© BusinessWire
10.04.2025
BAX
LISTED
NYSE
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
News Preview
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding...
Themefolio
Profiler
Peergroup
© BusinessWire
26.03.2025
BAX
LISTED
NYSE
Baxter to Host Annual Meeting of Stockholders in Virtual Format
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2025 Annual Meeting) in a virtual format on Tuesday, May 6, 2025 at 9 a.m., Central Time, as disclosed in Baxter’s proxy statement for the 2025 Annual Meeting. Online access to the 2025 Annual Meeting will begin at 8:45 a.m., Central Ti...
Themefolio
Profiler
Peergroup
© BusinessWire
04.03.2025
BAX
LISTED
NYSE
Baxter Unveils Voalte Linq Device Powered by Scotty Assistant at HIMSS25 to Advance Voice-Activated Technology in Hospital Settings
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, today unveiled Voalte Linq device powered by Scotty assistant, the company’s first voice-activated technology, at the 2025 HIMSS Global Healthcare Conference. Voalte Linq, a lightweight, wearable badge, is powered by Scotty assistant, a voice-activated technology, to better enable effi...
Themefolio
Profiler
Peergroup
© BusinessWire
25.02.2025
BAX
LISTED
NYSE
Baxter to Present at Barclays 27th Annual Global Healthcare Conference
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be...
Themefolio
Profiler
Peergroup
© BusinessWire
20.02.2025
BAX
LISTED
NYSE
Baxter Reports Fourth-Quarter and Full-Year 2024 Results
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2024, and provided its financial guidance for first-quarter and full-year 2025.
“Our 2024 performance and related strategic milestones reflect Baxter’s growing momentum in our pursuit of enhanced value for pati...
Themefolio
Profiler
Peergroup
© BusinessWire
18.02.2025
BAX
LISTED
NYSE
Baxter to Present at TD Cowen 45th Annual Health Care Conference
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the TD Cowen 45th Annual Health Care Conference on Wednesday, March 5, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:10 p.m. Eastern Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be availab...
Themefolio
Profiler
Peergroup
© BusinessWire
17.02.2025
BAX
LISTED
NYSE
Baxter to Present at Raymond James & Associates’ 46th Annual Institutional Investors Conference
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James & Associates’ 46th Annual Institutional Investors Conference on Monday, March 3, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:05 p.m. Eastern Time.
The live webcast of Baxter’s presentation can be accessed at ww...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
BAX
LISTED
NYSE
Baxter to Present at Citi - 2025 Medtech & Life Sciences Access Day
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Citi - 2025 Medtech & Life Sciences Access Day on Thursday, February 27, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will...
Themefolio
Profiler
Peergroup
© BusinessWire
11.02.2025
BAX
LISTED
NYSE
Baxter Declares Quarterly Dividend
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on April 1, 2025, to stockholders of record as of Feb. 28, 2025. The indicated annual dividend rate is $0.68 per share of common stock.
About...
Themefolio
Profiler
Peergroup
© BusinessWire
03.02.2025
BAX
LISTED
NYSE
Baxter Announces CEO Retirement and Appointment of COO
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief executive officer (CEO), will retire from his executive roles with the company, effective immediately. He will serve in an advisory capacity through Oct. 31, 2025.
The Baxter Board of Directors has appointed lead...
Themefolio
Profiler
Peergroup
© BusinessWire
22.01.2025
BAX
LISTED
NYSE
Baxter to Host Fourth-Quarter 2024 Financial Results Conference Call for Investors
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2024 financial results on Thursday, February 13, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I2823858 to pre-register for the call and rece...
Themefolio
Profiler
Peergroup
© BusinessWire
18.12.2024
BAX
LISTED
NYSE
Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. José (Joe) E. Almeida, Baxter's chair, president and chief executive officer, is scheduled to present at 10:30 a.m. Pacific Time.
The live webcast of Baxter’s presentation can be accessed a...
Themefolio
Profiler
Peergroup
© BusinessWire
11.12.2024
BAX
LISTED
NYSE
Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S.
News Preview
Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product launches in the U.S., joining the previous five launches announced in April of this year and marking a total of 10 U.S. injectable product launches in 2024.
“Our Pharmaceuticals teams a...
Themefolio
Profiler
Peergroup
© BusinessWire
19.11.2024
BAX
LISTED
NYSE
Baxter to Present at 7th Annual Evercore HealthCONx Conference
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 7th Annual Evercore HealthCONx Conference on Thursday, December 5, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 9:10 a.m. Eastern Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be availa...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2024
BAX
LISTED
NYSE
Baxter to Present at Jefferies London Healthcare Conference
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 11:00 a.m. Greenwich Mean Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2024
BAX
LISTED
NYSE
Baxter to Present at Stifel 2024 Healthcare Conference
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Stifel 2024 Healthcare Conference on Monday, November 18, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 8:35 a.m. Eastern Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for r...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
